Furan-induced dose-response relationships for liver cytotoxicity, cell proliferation, and tumorigenicity (furan-induced liver tumorigenicity)

Experimental and Toxicologic Pathology

Volumn 61, Issue 2, 2009, Pages 101-111

  Moser, Glenda J ^a   Foley, Julie ^b   Burnett, Merrie ^a   Goldsworthy, Thomas L ^a   Maronpot, Robert ^b  

^a INTEGRATED LABORATORY SYSTEMS   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Cytotoxic; Furan; Inflammation; Mouse liver carcinogenesis; Proliferation

Indexed keywords

FURAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BODY WEIGHT; CARCINOGENICITY; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; FEMALE; HISTOPATHOLOGY; LIVER ADENOMA; LIVER CARCINOGENESIS; LIVER CARCINOMA; LIVER NECROSIS; LIVER TOXICITY; MORTALITY; MOUSE; NONHUMAN;

ANIMALS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FURANS; HEPATITIS, TOXIC; LIVER; LIVER FUNCTION TESTS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED STRAINS; NECROSIS;

MUS; RODENTIA;

EID: 60849118640     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2008.06.006     Document Type: Article

References (40)

1. Bailer A.J., and Portier C.J. Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples. Biometrics 44 (1988) 417-431
2. Becker F.F. Thioacetamide hepatocarcinogenesis. J Natl Cancer Inst 71 (1983) 553-558
3. Bieler G.S., and Williams R.L. Ratio estimates, the delta methods, and quantal response tests for increased carcinogenicity. Biometrics 49 (1993) 793-801
4. Burka L.T., Washburn K.D., and Irwin R.D. Disposition of [14C]furan in the male rat. J Toxicol Environ Health 34 (1991) 245-257
5. Bursch W., Düsterberg B., and Schulte-Hermann R. Growth, regression and cell death in rat liver as related to tissue levels of the hepatomitogen cyproterone acetate. Arch Toxicol 59 (1986) 221-227
6. Butterworth B.E., Sprankle C.S., Goldsworthy S.M., Wilson D.M., and Goldsworthy T.L. Expression of myc, fos, and Ha-ras in the livers of furan-treated F344 rats and B6C3F1 mice. Mol Carcinog 9 (1994) 24-32
7. Butterworth B.E., Templin M.V., Borghoff S.J., Conolly R.B., Kedderis G.L., and Wolf D.C. The role of regenerative cell proliferation in chloroform-induced cancer. Toxicol Lett 82/83 (1995) 23-26
8. Cohen S.M., Putilo D.T., and Ellwein L.B. Pivotal role of increased cell proliferation in human carcinogenesis. Modern Path 4 (1991) 371-382
9. Cox D.R. Regression models and life-tables. J R Stat Soc B34 (1972) 187-220
10. Drinkwater N.R. Genetic control of hepatocarcinogenesis in C3H mice. Drug Metab Rev 26 (1994) 201-208
11. Elia M.C., Storer R.D., Harmon L.S., Kraynak A.R., McKelvey T.W., Hertzog P.R., et al. Cytotoxicity as measured by trypan blue as a potentially confounding variable in the in vitro alkaline elution/rat hepatocyte assay. Mutat Res 291 (1993) 193-205
12. Fransson-Steen R., Goldsworthy T.L., Kedderis G.L., and Maronpot R.R. Furan-induced cell proliferation and apoptosis in B6C3F1 mouse liver. Toxicolog 118 (1997) 195-204
13. Goldsworthy T., Fransson-Steen R., and Maronpot R.R. Importance of and approaches to quantification of hepatocyte apoptosis. Toxicol Pathol 24 (1996) 24-35
14. Hard G.C., Boorman G.A., and Wolf D.C. Re-evaluation of the 2-year chloroform drinking water carcinogenicity bioassay in Osborne-Mendel rats supports chronic renal tubule injury as the mode of the action underlying the renal tumor response. Toxicol Sci 53 (2000) 237-244
15. Haseman J.K., Haley J.R., and Morris R.W. Spontaneous neoplasms incidences in Fischer344 rats and B6C3F1 mice in two-year carcinogenicity studies: a national toxicology program update. Toxicol Pathol 26 (1998) 428-441
16. IARC (International Agency for Research on Cancer). Monographs on the evaluation of carcinogenic risks to humans. Alcohol drinking vol. 44 (1988), IARC, Lyon, France
17. IARC (International Agency for Research on Cancer). IARC monographs on the evaluation of carcinogenic risks to humans: hepatitis viruses vol. 59 (1994), IARC, Lyon, France
18. IARC (International Agency for Research on Cancer). IARC monographs on the evaluation of carcinogenic risks to humans: dry cleaning, some chlorinated solvents, and other industrial chemicals vol. 63 (1995), IARC, Lyon, France
19. ILAR (Institute of Laboratory Animal Resource). Commission on Life Sciences, National Research Council. Guide for the Care and Use of Laboratory Animals. HHS No. 86. Washington, DC, 1996.
20. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
21. Kanji G.K. 100 Statistical Tests (1999), Sage Publications Inc., Thousand Oaks, CA
22. Kedderis G.L., and Held S.D. Prediction of furan pharmacokinetics from hepatocyte studies: comparison of bioactivation and hepatic dosimetry in rats, mice and humans. Toxicol Appl Pharmacol 140 (1996) 124-130
23. Ledda-Columbano G.M., and Columbano A. Apoptosis and hepatocarcinogenesis. In: Tomei L.D., and Cope F.O. (Eds). Apoptosis II: the molecular basis of cell death in disease (1991), Cold Spring Harbor Laboratory Press 101-119
24. Maga J. Furans in foods. Crit Rev Food Sci Nutr 11 (1979) 356-366
25. Maronpot R.R., Harda T., Murthy A.S.K., and Boorman G.A. Documenting foci of hepatocellular alteration in two-year carcinogenicity studies: current practices of the National Toxicology Program. Toxicol Pathol 17 (1989) 675-684
26. Maronpot R.R., Giles H.D., Dykes D.J., and Irwin R.D. Furan-induced hepatic cholangiocarcinomas in Fischer 344 rats. Toxicol Pathol 19 (1991) 561-570
27. McClain R.M. The significance of hepatic microsomal enzyme induction and altered thyroid function in rats; implications for thyroid gland neoplasia. Toxicol Pathol 17 (1989) 294-306
28. Mugford C.A., and Kedderis G.L. Cytotoxic Rodent carcinogens: investigation of the role of cytolethality in Furan-mediated DNA damage. CIIT Activities 17 (1997)
29. 2+ in cell killing. Chem Res Toxicol 3 (1990) 484-494
30. NTP (National Toxicology Program). Toxicology and carcinogenesis studies of furan (CAS No. 110-00-9) in F344 rats and B6C3F1 mice (gavage studies). Technical Report Series no. 402, NIH Publication No. 93-2857. National Toxicology Program, Research Triangle Park, NC, and Bethesda, MD, 1993.
31. Nyska A., Moomnaw C.R., Foley J.F., Maronpot R.R., Malarkey D.E., et al. The hepatic endothelial carcinogen Riddelliine induces endothelial apoptosis, mitosis, S phase, and p53 and hepatocyte vascular endothelial growth factor expression after short-term exposure. Toxicol Appl Pharmacol 184 (2002) 153-164
32. Piegorsch W.W., and Bailer A.J. Statistics for environmental biology and toxicology, section 6.3.2 (1997), Chapman & Hall, London
33. Portier C.J., and Bailer A.J. Testing for increased carcinogenicity using a survival-adjusted quantal response test. Fundam Appl Toxicol 12 (1989) 731-737
34. Preston-Martin S., Pike M.C., Ross R.K., Jones P.A., and Henderson B.E. Increase cell division as a cause of human cancer. Cancer Res 50 (1990) 7415-7421
35. 2+ antagonists inhibit DNA fragmentation and toxic cell death induced by acetaminophen. FASEB J 7 (1993) 453-463
36. Reynolds S.H., Stowers S.J., Maronpot R.R., Anderson M.W., and Aaronson S.A. Detection and identification of activated oncogenes in spontaneous occurring benign and malignant hepatocellular tumors of B6C3F1 mouse. Proc Natl Acad Sci USA 83 (1987) 33-37
37. Tarone R.E. Tests for trend in life table analysis. Biometrika 62 (1975) 679-682
38. Tsukamoto H., Matsuok M., and French S.W. Experimental models of hepatic fibrosis: a review. Sem Liver Dis 10 (1990) 5665
39. US FDA (United States Food and Drug Administration). Department of Health and Human Services. 2004, 〈www.cfsan.fda.gov/~dms/furandat.html〉.
40. Wilson D.M., Goldsworthy T.L., Popp J.A., and Butterworth B.E. Evaluation of genotoxicity, pathological lesions, and cell proliferation in liver of rats and mice treated with furan. Environ Mol Mutagen 19 (1992) 209-222